Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective

• المؤلفون الرئيسيون: Permsuwan U., Thavorn K., Dilokthornsakul P., Saokaew S., Chaiyakunapruk N.
• التنسيق: دورية
• منشور في: 2017
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85023172990&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40121

© 2017 Informa UK Limited, trading as Taylor & Francis Group. Aims: An economic evidence is a vital tool that can inform the decision to use costly insulin analogs. This study aimed to evaluate long-term cost-effectiveness of insulin detemir (IDet) compared with insulin glargine (IGlar) in typ...